Trading of Beximco Pharma GDRs resumes on London Stock Exchange

Trading of the Global Depositary Receipts (GDRs) of Beximco Pharmaceuticals PLC on the London Stock Exchange (LSE) resumed yesterday (26 June) after the suspension imposed earlier this year was lifted, following regulatory intervention facilitated by the DSE Brokers Association of Bangladesh (DBA).

Beximco Pharmaceuticals, the only Bangladeshi company listed on the LSE since 2004, had its GDRs suspended from trading on 2 January after failing to publish its audited financial statements for the year ended 30 June 2025, along with subsequent financial reports, within the required timeframe.

According to LSE listing rules, a security suspended for six consecutive months may face delisting if the underlying issues remain unresolved. The company’s deadline to address the matter was 2 July.

Concerned about the potential delisting, foreign institutional and individual investors appealed to the Bangladesh Securities and Exchange Commission (BSEC) to take the necessary steps to safeguard the listing. They also sought the support of the DBA.

In response, the DBA, led by its President Saiful Islam, coordinated with the BSEC and the company’s management, urging swift regulatory action to protect investors’ interests.

Following the initiative, the BSEC allowed Beximco Pharmaceuticals’ board to hold a special meeting to approve and publish its outstanding financial statements, including the third-quarter results for FY2024-25, the audited annual financial statements for FY2024-25, and the first three quarterly reports for FY2025-26.

The publication of these reports enabled the company to meet the LSE’s reporting requirements, leading to the withdrawal of the trading suspension and the resumption of GDR trading yesterday.

The DBA said the development will strengthen the international credibility of Bangladesh’s capital market, boost foreign investor confidence, and reinforce the country’s standing in global financial markets.

On behalf of the DBA, President Saiful Islam thanked Finance and Planning Minister Amir Khosru Mahmud Chowdhury; Tanvir Ghani, special assistant to the prime minister on investment and capital market affairs; BSEC Chairman Masud Khan; commission officials; the board and management of Beximco Pharmaceuticals; and members of the media for their support in resolving the issue.

The DBA said it hopes the government will continue pursuing investor-friendly policies and reforms to attract greater foreign investment into Bangladesh’s capital market.